The Waxing, Waning, and Predictors of Humoral Responses to Vector-Based SARS-CoV-2 Vaccine in Hemodialysis Patients
Hemodialysis (HD) patients are vulnerable to coronavirus disease 2019 (COVID-19) and have a high mortality rate. We evaluated the anti-SARS-CoV-2 spike protein antibody (ACOV2S) levels in 385 HD patients before and 4 and 8 weeks after the second dose of vector-based ChAdOx1 nCoV-19 vaccine. For stud...
Glavni autori: | , , , , , , |
---|---|
Format: | Članak |
Jezik: | English |
Izdano: |
MDPI AG
2022-09-01
|
Serija: | Vaccines |
Teme: | |
Online pristup: | https://www.mdpi.com/2076-393X/10/9/1537 |